Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| 1 |
Linde
LIN
|
+$397M |
| 2 |
NVIDIA
NVDA
|
+$373M |
| 3 |
AT&T
T
|
+$295M |
| 4 |
Energy Select Sector SPDR Fund
XLE
|
+$274M |
| 5 |
Walmart
WMT
|
+$273M |
Top Sells
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.19B |
| 2 |
Lam Research
LRCX
|
+$379M |
| 3 |
Apple
AAPL
|
+$367M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$320M |
| 5 |
Boeing
BA
|
+$299M |
Sector Composition
| 1 | Technology | 16.96% |
| 2 | Healthcare | 16.1% |
| 3 | Financials | 12.4% |
| 4 | Consumer Discretionary | 11.37% |
| 5 | Industrials | 11.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
NAGE
3126
Niagen Bioscience, Inc. Common Stock
NAGE
$757M
| $785K | ﹤0.01% |
512,912
-149,955
| -23% | -$230K |
|
3127
iShares Global Tech ETF
IXN
$6.03B
| $783K | ﹤0.01% |
14,400
-1,644
| -10% | -$89.4K |
|
3128
Mine Safety
MSA
$6.59B
| $783K | ﹤0.01% |
5,865
-62,912
| -91% | -$8.4M |
|
3129
Tango Therapeutics
TNGX
$848M
| $783K | ﹤0.01% |
198,163
+168,948
| +578% | +$668K |
|
3130
Blue Ridge Bankshares
BRBS
$385M
| $780K | ﹤0.01% |
76,481
-6,500
| -8% | -$66.3K |
|
3131
Mativ Holdings
MATV
$670M
| $780K | ﹤0.01% |
+36,332
| New | +$780K |
|
3132
Freedom Holding
FRHC
$10.2B
| $779K | ﹤0.01% |
10,838
+4,410
| +69% | +$317K |
|
3133
Prelude Therapeutics
PRLD
$65.7M
| $778K | ﹤0.01% |
136,519
+86,783
| +174% | +$495K |
|
3134
Israel Acquisitions Corp Unit
ISRLU
| $777K | ﹤0.01% |
+75,000
| New | +$777K |
|
3135
Peoples Bancorp of North Carolina
PEBK
$167M
| $777K | ﹤0.01% |
+24,451
| New | +$777K |
|
|
TARO
3136
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $777K | ﹤0.01% |
+31,934
| New | +$777K |
|
3137
Utah Medical Products
UTMD
$200M
| $772K | ﹤0.01% |
+8,151
| New | +$772K |
|
3138
Sibanye-Stillwater
SBSW
$6.05B
| $769K | ﹤0.01% |
92,409
+32,980
| +55% | +$274K |
|
3139
Avanos Medical
AVNS
$552M
| $766K | ﹤0.01% |
25,741
+4,830
| +23% | +$144K |
|
3140
Riot Platforms
RIOT
$6.51B
| $765K | ﹤0.01% |
76,565
+46,142
| +152% | +$461K |
|
3141
APi Group
APG
$14.6B
| $763K | ﹤0.01% |
50,909
-1,237,935
| -96% | -$18.6M |
|
3142
America Movil
AMX
$61.8B
| $761K | ﹤0.01% |
36,158
-19,278
| -35% | -$406K |
|
3143
Rekor Systems
REKR
$186M
| $756K | ﹤0.01% |
604,996
+25,029
| +4% | +$31.3K |
|
3144
GoHealth
GOCO
$77.4M
| $753K | ﹤0.01% |
46,282
+27,395
| +145% | +$446K |
|
3145
FNB Corp
FNB
$5.76B
| $751K | ﹤0.01% |
+64,743
| New | +$751K |
|
3146
Transmedics
TMDX
$4.08B
| $751K | ﹤0.01% |
9,917
-133,047
| -93% | -$10.1M |
|
3147
MoonLake Immunotherapeutics
MLTX
$3.25B
| $750K | ﹤0.01% |
+35,071
| New | +$750K |
|
|
QVCGA
3148
QVC Group, Inc. Series A Common Stock
QVCGA
$116M
| $749K | ﹤0.01% |
15,164
-254,695
| -94% | -$12.6M |
|
3149
NewAmsterdam Pharma
NAMS
$2.76B
| $748K | ﹤0.01% |
+55,633
| New | +$748K |
|
3150
Global Water Resources
GWRS
$272M
| $747K | ﹤0.01% |
60,061
+4,620
| +8% | +$57.5K |
|